About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker GNLX

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Nov 3, 2026Joseph Cappello
Chief Technical Officer
GNLX
Genelux Corporation
Sale668$2.04$1,363 SaleForm 4 ↗
Nov 3, 2026Thomas Zindrick
President and CEO
GNLX
Genelux Corporation
Sale3,089$2.05$6,317 SaleForm 4 ↗
Nov 3, 2026Yong Yu
Chief Scientific Officer
GNLX
Genelux Corporation
Sale668$2.01$1,344 SaleForm 4 ↗
Aug 31, 2026Joseph Cappello
Chief Technical Officer
GNLX
Genelux Corporation
Sale10,257$2.74$28.1K SaleForm 4 ↗
Aug 31, 2026Thomas Zindrick
President and CEO
GNLX
Genelux Corporation
Sale34,463$2.67$92.0K SaleForm 4 ↗
Aug 31, 2026Yong Yu
Chief Scientific Officer
GNLX
Genelux Corporation
Sale9,683$2.75$26.6K SaleForm 4 ↗
Aug 4, 2026Yong Yu
Chief Scientific Officer
GNLX
Genelux Corporation
Sale653$2.94$1,920 SaleForm 4 ↗
Aug 4, 2026Joseph Cappello
Chief Technical Officer
GNLX
Genelux Corporation
Sale653$2.95$1,926 SaleForm 4 ↗
Aug 4, 2026Thomas Zindrick
President and CEO
GNLX
Genelux Corporation
Sale3,023$2.95$8,918 SaleForm 4 ↗
Jul 1, 2026John W. Smither
Director
GNLX
Genelux Corporation
Sale12,000$2.91$34.9K SaleForm 4 ↗
Jun 3, 2026Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale192$2.93$563 SaleForm 4 ↗
Jun 1, 2026John Thomas
Director
GNLX
Genelux Corporation
Sale10,000$2.98$29.8K SaleForm 4 ↗
May 11, 2026Joseph Cappello
Chief Technical Officer
GNLX
Genelux Corporation
Sale605$2.97$1,797 SaleForm 4 ↗
May 11, 2026Yong Yu
Chief Scientific Officer
GNLX
Genelux Corporation
Sale605$2.97$1,797 SaleForm 4 ↗
May 11, 2026Thomas Zindrick
President and CEO
GNLX
Genelux Corporation
Sale2,798$2.94$8,226 SaleForm 4 ↗
May 11, 2026Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale270$2.98$805 SaleForm 4 ↗
Mar 25, 2026Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale240$2.51$602 SaleForm 4 ↗
Mar 24, 2026Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale345$2.42$835 SaleForm 4 ↗
Mar 24, 2026Joseph Cappello
Chief Technical Officer
GNLX
Genelux Corporation
Sale906$2.42$2,193 SaleForm 4 ↗
Mar 24, 2026Yong Yu
SVP, Clinical Development
GNLX
Genelux Corporation
Sale906$2.42$2,193 SaleForm 4 ↗
Mar 24, 2026Thomas Zindrick
President and CEO
GNLX
Genelux Corporation
Sale3,582$2.42$8,668 SaleForm 4 ↗
Mar 2, 2026John Thomas
Director
GNLX
Genelux Corporation
Sale10,000$2.90$29.0K SaleForm 4 ↗
Dec 5, 2025Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale165$4.69$774 SaleForm 4 ↗
Dec 1, 2025John Thomas
Director
GNLX
Genelux Corporation
Sale10,000$5.00$50.0K SaleForm 4 ↗
Nov 17, 2025Thomas Zindrick
President and CEO
GNLX
Genelux Corporation
Sale4,509$5.37$24.2K SaleForm 4 ↗
Nov 17, 2025Yong Yu
SVP, Clinical Development
GNLX
Genelux Corporation
Sale973$5.37$5,225 SaleForm 4 ↗
Nov 17, 2025Joseph Cappello
Chief Technical Officer
GNLX
Genelux Corporation
Sale973$5.37$5,225 SaleForm 4 ↗
Nov 17, 2025Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale343$5.37$1,842 SaleForm 4 ↗
Sep 3, 2025Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale580$3.36$1,949 SaleForm 4 ↗
Aug 21, 2025Thomas Zindrick
President and CEO
GNLX
Genelux Corporation
Sale12,673$3.33$42.2K SaleForm 4 ↗
Aug 21, 2025Yong Yu
SVP, Clinical Development
GNLX
Genelux Corporation
Sale3,219$3.36$10.8K SaleForm 4 ↗
Aug 21, 2025Joseph Cappello
Chief Technical Officer
GNLX
Genelux Corporation
Sale1,463$3.36$4,916 SaleForm 4 ↗
Aug 21, 2025Joseph Cappello
Chief Technical Officer
GNLX
Genelux Corporation
Sale1,270$3.33$4,229 SaleForm 4 ↗
Aug 21, 2025Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale1,244$3.36$4,180 SaleForm 4 ↗
May 12, 2025Sean Ryder
General Counsel
GNLX
Genelux Corporation
Sale4,475$2.92$13.1K SaleForm 4 ↗
May 12, 2025Thomas Zindrick
President and CEO, Director
GNLX
Genelux Corporation
Sale10,764$2.92$31.4K SaleForm 4 ↗
May 12, 2025Yong Yu
VP, Clinical Trial Operations
GNLX
Genelux Corporation
Sale5,579$2.92$16.3K SaleForm 4 ↗
May 12, 2025Joseph Cappello
VP, Pharmaceutical Development
GNLX
Genelux Corporation
Sale4,737$2.92$13.8K SaleForm 4 ↗
May 12, 2025Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale1,259$2.92$3,676 SaleForm 4 ↗
Dec 30, 2024James L. Tyree
Director
GNLX
Genelux Corporation
Sale3,460$2.46$8,512 SaleForm 4 ↗
Dec 16, 2024Thomas Zindrick
President and CEO, Director
GNLX
Genelux Corporation
Sale14,315$2.34$33.5K SaleForm 4 ↗
Dec 16, 2024Lourie S. Zak
Chief Financial Officer
GNLX
Genelux Corporation
Sale2,103$2.34$4,921 SaleForm 4 ↗
Dec 16, 2024Ralph Smalling
Head of Regulatory
GNLX
Genelux Corporation
Sale2,510$2.34$5,873 SaleForm 4 ↗
Dec 16, 2024Joseph Cappello
VP, Pharmaceutical Development
GNLX
Genelux Corporation
Sale6,300$2.34$14.7K SaleForm 4 ↗

44 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 9:28 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances